Skip to main content
Clinical Trials/CTRI/2016/02/006644
CTRI/2016/02/006644
Completed
N/A

Multicenter observational study on epidemiology, treatment and outcome of Mucormycosis in India

MYLAN PHARMACEUTICALS PRIVATE LIMITED0 sites465 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Patients who diagnosed with MucormycosisHealth Condition 2: B46- Zygomycosis
Sponsor
MYLAN PHARMACEUTICALS PRIVATE LIMITED
Enrollment
465
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 31, 2017
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Any age group of patients with confirmed \& probable diagnosis of Mucormycosis will be enrolled for this study

Exclusion Criteria

  • Any subject without a confirmed diagnosis of mucormycosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials